Lupus Foundation of America11h
Lupus Foundation of America Announces LFA LIFT to Accelerate Development of New Lupus Treatments
Today, the Lupus Foundation of America announced a new, groundbreaking collaborative lupus clinical trial program – LFA Lupus ...
TMCnet1d
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and neurological diseases; Initial data for NKX ...
Fierce Biotech1d
Drug discovery pact between Charles River and Valo Health nets potential lupus asset for Flagship’s Pioneering Medicines
The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...
Yale researchers use lupus antibody to possibly treat glioblastoma
Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...
Argenx: The Magic May Be Already Priced In
Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...
Healio3d
Emerging cardio-rheumatology clinics manage ‘broad and vast’ crossover population
Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...
Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth
Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...